CCGs face legal threat for offering off-label drug for wet AMD

被引：3
作者：
Cohen, Deborah
机构：
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2017年 / 359卷
关键词：
D O I：
10.1136/bmj.j5021
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 4 条
[1]   INVESTIGATION Are the odds shifting against pharma in the fight for cheaper treatment for macular degeneration? [J].
Cohen, Deborah .
BMJ-BRITISH MEDICAL JOURNAL, 2017, 359 :j5016
[2]   BANNER Why have UK doctors been deterred from prescribing Avastin? [J].
Cohen, Deborah .
BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
[3]   Commentary: NHS patients should have a choice of drug for wet age-related macular degeneration, despite pressure from pharma [J].
Hambleton, David .
BMJ-BRITISH MEDICAL JOURNAL, 2017, 359 :j5013
[4]   Licence to save: a UK survey of anti-VEGF use for the eye in 2015 [J].
Shalaby, A. K. ;
Lewis, K. ;
Bush, K. ;
Meredith, P. R. ;
Di Simplicio, S. ;
Lockwood, A. J. .
EYE, 2016, 30 (11) :1404-1406
1